Invention Grant
US08633226B2 Piperidinyl derivative as a modulator of chemokine receptor activity
有权
哌啶基衍生物作为趋化因子受体活性的调节剂
- Patent Title: Piperidinyl derivative as a modulator of chemokine receptor activity
- Patent Title (中): 哌啶基衍生物作为趋化因子受体活性的调节剂
-
Application No.: US13628180Application Date: 2012-09-27
-
Publication No.: US08633226B2Publication Date: 2014-01-21
- Inventor: Joseph B. Santella
- Applicant: Bristol-Myers Squibb Company
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Hong Liu; Laurelee A. Duncan
- Main IPC: A61K31/445
- IPC: A61K31/445 ; C07D211/00
Abstract:
The present application describes the compound of formula (I): or stereoisomers or pharmaceutically acceptable salts thereof. In addition, methods of treating and preventing inflammatory diseases such as asthma and allergic diseases, as well as autoimmune pathologies such as rheumatoid arthritis and arthrosclerosis using the compound of the invention are disclosed.
Public/Granted literature
- US20130023564A1 PIPERIDINYL DERIVATIVE AS A MODULATOR OF CHEMOKINE RECEPTOR ACTIVITY Public/Granted day:2013-01-24
Information query
IPC分类:
